Margaret A. Hamburg, M.D.
Interim Vice President, Global Biological Policy and Programs
A discussion with NTI Board Member Dr. Margaret Hamburg, an internationally recognized leader in public health and medicine. Dr. Hamburg previously served as Commissioner of the Food and Drug Administration and most recently served as Foreign Secretary of the National Academy of Medicine.
The COVID-19 pandemic has exposed many weaknesses across the global community in preparedness and response to pandemics. As a leader in international health policy and vaccine development, Dr. Hamburg has worked for more than two decades on U.S preparedness for epidemics and pandemics and will share her perspectives on the COVID-19 vaccines, current therapeutics and the nexus between preparedness and biosecurity.
Dr. Hamburg serves as chair of the NTI | bio Advisory Group. She served for almost six years as FDA Commissioner, where she was known for advancing regulatory science, streamlining and modernizing FDA’s regulatory pathways, and globalization of the agency. Before joining the FDA, Hamburg was founding vice president and senior scientist at NTI. Previous government positions include Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services, Health Commissioner for New York City, and Assistant Director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.